Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Tianjia J. Ge"'
Publikováno v:
ACS Synthetic Biology
Dynamic RNA nanotechnology with small conditional RNAs (scRNAs) offers a promising conceptual approach to introducing synthetic regulatory links into endogenous biological circuits. Here, we use human cell lysate containing functional Dicer and RNase
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cede50c09a6acf340852610ffebd3824
https://doi.org/10.1021/acssynbio.8b00424
https://doi.org/10.1021/acssynbio.8b00424
Dynamic RNA nanotechnology with small conditional RNAs (scRNAs) offers a promising conceptual approach to introducing synthetic regulatory links into endogenous biological circuits. Here, we use human cell lysate containing functional Dicer and RNase
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::192916c69372359dc074f17d86dfd29a
https://doi.org/10.1101/439273
https://doi.org/10.1101/439273
Autor:
Tianjia J. Ge, Viswam S. Nair, Utkan Demirci, Kenneth Lau, Andrew Sabour, Gayatri Gowrishankar, Robert Sinclair, Sharon J. Pitteri, Fei Liu, Abel Bermudez, Masamitsu Kanada, Raymond G. Sierra, Sanjiv S. Gambhir, Jesse V. Jokerst, Tanya Stoyanova, Kaushik Sridhar, Vigneshwaran Mani, Ophir Vermesh, Steven J. Madsen, Edwin Chang, En-Chi Hsu
Circulating tumor-derived extracellular vesicles (EVs) have emerged as a promising source for identifying cancer biomarkers for early cancer detection. However, the clinical utility of EVs has thus far been limited by the fact that most EV isolation
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::02806865f7f7b099dd114068bdce5114
https://europepmc.org/articles/PMC5983373/
https://europepmc.org/articles/PMC5983373/
Autor:
Shan X. Wang, Amin Aalipour, Tianjia J. Ge, Yamil Saenz, Yue Guo, Ophir Vermesh, Michael Bachmann, Seung-min Park, Kerstin Mueller, Alfredo Green, Chin Chun Ooi, Sanjiv S. Gambhir, Yoshiaki Mitsutake, Hamed Arami
Publikováno v:
Cancer Research. 77:3796-3796
Background: Liquid biopsies have long promised to enable earlier cancer diagnosis and tailored therapy. However, circulating tumor cells (CTCs) are extremely rare (1-10 cells per mL blood), limiting their clinical utility. There are too few CTCs in a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::340b55545086e395a5fe43fdc3e3bebf
https://doi.org/10.1158/1538-7445.am2017-3796
https://doi.org/10.1158/1538-7445.am2017-3796